95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-15.06%
Negative revenue growth while NEM stands at 10.44%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.06%
Negative gross profit growth while NEM is at 38.44%. Joel Greenblatt would examine cost competitiveness or demand decline.
-1735.83%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1735.83%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3021.48%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-2983.33%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-2983.33%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1836.26%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1836.26%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-10.91%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-10.91%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-10.91%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.40%
AR growth is negative/stable vs. NEM's 165.87%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
6.46%
Inventory shrinking or stable vs. NEM's 32.70%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
-26.32%
Negative asset growth while NEM invests at 146.81%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-26.93%
We have a declining book value while NEM shows 114.95%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.28%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.